Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Guo-hui Cui"'
Autor:
Ming-Ci Cai, Shu Cheng, Hong-Mei Jing, Yan Liu, Guo-Hui Cui, Ting Niu, Jian-Zhen Shen, Liang Huang, Xin Wang, Yao-Hui Huang, Li Wang, Peng-Peng Xu, Wei-Li Zhao
Publikováno v:
The Lancet Regional Health. Western Pacific, Vol 50, Iss , Pp 101160- (2024)
Summary: Background: Peripheral T-cell lymphoma (PTCL) is a heterogeneous disease with dismal outcomes. We conducted an open-label, phase 2 nonrandomised, externally controlled study to evaluate the efficacy and safety of targeted agents plus CHOP (c
Externí odkaz:
https://doaj.org/article/7de9b0251dbf4d408a2dc6d1d4a01309
Autor:
Xin-xin Cao, Jie Jin, Cheng-cheng Fu, Shu-hua Yi, Wei-li Zhao, Zi-min Sun, Wei Yang, Deng-ju Li, Guo-hui Cui, Jian-da Hu, Ting Liu, Yong-ping Song, Bing Xu, Zun-min Zhu, Wei Xu, Ming-zhi Zhang, Ya-min Tian, Bin Zhang, Ren-bin Zhao, Dao-bin Zhou
Publikováno v:
EClinicalMedicine. 52
Orelabrutinib is a novel, small molecule, selective irreversible Bruton tyrosine kinase inhibitor. The purpose of this study was to evaluate the efficacy and safety of orelabrutinib in patients with relapsed or refractory Waldenström's macroglobulin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b2bca91caa48f8fe8ef92249a130f349
https://pubmed.ncbi.nlm.nih.gov/36313145
https://pubmed.ncbi.nlm.nih.gov/36313145
Publikováno v:
ChemMedChem. 17(9)
CRISPR/Cas system has become one of the most powerful techologies in biomedical research, and has showed great potentials in the gene related diseases. However, efficient delivery systems of CRISPR/Cas to target cells remains challenging. In recent y
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80f18295b7ba9682a995fefeef165cc4
https://pubmed.ncbi.nlm.nih.gov/35261159
https://pubmed.ncbi.nlm.nih.gov/35261159
Autor:
Baojia Zheng, Hui Wang, Guo-Hui Cui, Qian-Fang Guo, Lu-Lu Si, Hui-Jun Yan, Dan-Yun Fang, Li-Fang Jiang, Zhen-You Jiang, Jun-Mei Zhou
Publikováno v:
SSRN Electronic Journal.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7d8f0484a9a727a2a2e711a29c3fcf0c
https://doi.org/10.2139/ssrn.3474491
https://doi.org/10.2139/ssrn.3474491
Autor:
Shiqi Peng, Mei-Jin Zhang, Yi-Bing Zhang, Hua Yang, Guo-Hui Cui, Tian-Lan Zhang, Chen-Jie Fang, Rui Guo, Wei Feng, Chun-Hua Yan, Lele Li
Publikováno v:
Materials Letters. 66:79-82
A drug delivery system based on disulfide-linked MSN-folate conjugates is fabricated via co-condensation and post-grafting methods. The premature leakage before DDSs reach the specific site is eliminated due to the covalent conjugation, which is desi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b3dde6534c71c09a9687836e063506fe
https://doi.org/10.1016/j.matlet.2011.08.046
https://doi.org/10.1016/j.matlet.2011.08.046
Publikováno v:
Acta Pharmacologica Sinica. 26:873-880
Aim: To investigate anticancer effects and molecular mechanism of deguelin on human Burkitt's lymphoma Daudi cells in vitro and compare the cytotoxicities of deguelin on Daudi cells and human peripheral blood monocular cells (PBMC). Methods: The effe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8644e663ab4bdc7b0b164b2521885a2b
https://doi.org/10.1111/j.1745-7254.2005.00104.x
https://doi.org/10.1111/j.1745-7254.2005.00104.x
Publikováno v:
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi. 33(9)
To probe the cause for triggering HBV reactivation and possible management of the chronic hepatitis B individuals received imatinib.This study presented two cases of transient hepatitis B virus (HBV) reactivation and hepatic dysfunction during oral i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::2a5ee08115c27b9138df8ef147172c24
https://pubmed.ncbi.nlm.nih.gov/23336229
https://pubmed.ncbi.nlm.nih.gov/23336229
Publikováno v:
Chinese medical journal. 125(14)
Imatinib mesylate is a molecular targeted agent for treating chronic myeloid leukemia (CML) and gastrointestinal stromal tumor. Although imatinib mesylate is not regarded as an immunosuppressive agent, few studies have also shown that it may impair i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::de45e9cbece1065e488454dc5a38fc05
https://pubmed.ncbi.nlm.nih.gov/22882953
https://pubmed.ncbi.nlm.nih.gov/22882953
Publikováno v:
Ai zheng = Aizheng = Chinese journal of cancer. 27(3)
PI3K-Akt signal pathway is an important intracellular signal transduction pathway. It plays important roles in cell apoptosis and survival by affecting the activity of downstream effector molecules, and it is closely associated with the development a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::b72cac2300aedbed8a5ae519b3061188
https://pubmed.ncbi.nlm.nih.gov/18334129
https://pubmed.ncbi.nlm.nih.gov/18334129
Publikováno v:
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi. 28(2)
To investigate antitumor activity and molecular mechanism of deguelin to the human U937 leukaemia cells and to explore the mechanisms regulating cell cycle and nucleoporin 98 (Nup98) and nucleoporin 88 (Nup88) in vitro.The effects of deguelin on the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0872cb7301c42eb27b348f9e645af349
https://pubmed.ncbi.nlm.nih.gov/17650673
https://pubmed.ncbi.nlm.nih.gov/17650673